A retrospective multicenter efficacy study of patients treated with hypomethylating agent and venetoclax who subsequently proceeded to allogeneic hematopoietic cell transplantation (HCT)
Latest Information Update: 27 Jan 2022
At a glance
- Drugs Azacitidine (Primary) ; Decitabine (Primary) ; Venetoclax (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- 14 Dec 2021 Results presented at the 63rd American Society of Hematology Annual Meeting and Exposition
- 06 Jan 2021 New trial record
- 08 Dec 2020 Results presented at the 62nd Annual Meeting and Exposition of the American Society of Hematology